Gossamer Bio Inc — Cash Flow (NASDAQ:GOSS) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 176.36 M188.89 M187.03 M159.16 M3.47 M 94.41 M Cash from investing activities 215.34 M117.43 M1.03 M110.97 M29.02 M 88.03 M Cash from financing activities 312.54 M3.33 M117.09 M190.15 M11.49 M 2.47 M Free cash flow 174.86 M187.34 M186.62 M159.16 M3.47 M 94.33 M

新闻

Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates

Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com

Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates

Wedbush因试验结果下调Gossamer Bio股票评级

Gossamer Bio stock downgraded by Wedbush on trial results

Barclays因试验结果下调Gossamer Bio股票评级

Barclays cuts Gossamer Bio stock rating on trial results

Leerink因试验失败下调Gossamer Bio股票评级

Leerink cuts Gossamer Bio stock rating on trial miss

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%

美国股市收低；截至收盘道琼斯工业平均指数下跌1.66%

Tesla, Oracle among market cap stock movers on Monday